Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Editorial & Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Caixin Weekly Sneak Peek
Topics
Asia New Vision Forum
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
News Graphics
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
"Pfizer"
Cover Story: Chinese Pharma Turns to Global Deals to Cure Capital Crunch
healthy cells.
Pfizer
Inc., Merck & Co. Inc., and AbbVie Inc. have recently announced deals for
How Ozempic Maker Novo Nordisk’s Very Danish Capitalism Fueled Its Success, and Its Stumbles
of Friday, the company’s market capitalization was roughly $439 billion — more than
Pfizer
, Lockheed
China’s Zhifei Biological Links Up With GSK on Shingles Shots
approved and sold in China as the GSK vies with
Pfizer
Inc. for dominance in this new market. A study
Cover Story: Anti-Corruption Storm Sweeps China’s Health-Care Industry
Pharmaceutical Co. Ltd., where the cost of sales was 171% of 2022 revenue. By comparison,
Pfizer
Inc
Big Pharma Bets Big on China
Pfizer
, Merck and GE Healthcare, that foreign pharma companies could expect to benefit from China’s
Fosun Partners with Rongcan Biotech to Eye Alternatives to Develop mRNA Drugs
. drug giant
Pfizer
Inc., the vaccine has yet to be approved for the Chinese mainland and is only sold
Moderna Signs Deal to Make mRNA Vaccines for Chinese Market
of boosters last year. While Moderna and rival
Pfizer
Inc. are expecting more people to receive an
Commerce Minister Encourages More Investment by Foreign Drugmakers
pharmaceutical giants
Pfizer
Inc., Merck & Co. and AstraZeneca Plc as well as medical device
Pfizer
, China Drugmaker Partner to Sell Local Brand of Paxlovid
(Bloomberg) —
Pfizer
has struck a deal with Chinese drugmaker CSPC Pharmaceutical Group Ltd. to
Junshi Biosciences Aims to Raise $4.77 Million From International Share Sale
immune system to fight cancer. Western drugmakers including
Pfizer
Inc., Novartis AG and Eli Lilly
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通